Document Detail


Forearm compartment syndrome following thrombolytic therapy for acute myocardial infarction.
MedLine Citation:
PMID:  8070154     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thrombolytic therapy for myocardial infarction may contribute to bleeding complications when central venous or arterial access is required, but peripheral venous access is usually uncomplicated. We report a patient in whom tissue plasminogen activator and subsequent intravenous heparin exacerbated bleeding from a disrupted intravenous access site, leading to acute compartment syndrome requiring surgical decompression. This case emphasizes the risks associated with iatrogenic trauma during thrombolytic therapy.
Authors:
J Burnside; J M Costello; N J Angelastro; J Blankenship
Related Documents :
8141724 - Hirudin and hirulog.
9447334 - The gusto trial and the open artery theory.
10406064 - What an interventional cardiologist should know about the pharmacological treatment of ...
3521234 - Coronary thrombolytic therapy: state of the art.
1637734 - Recovery of myocardial function in the hibernating heart.
21295134 - Differential effect of nadph oxidase and xanthine oxidase inhibition on sympathetic rei...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Clinical cardiology     Volume:  17     ISSN:  0160-9289     ISO Abbreviation:  Clin Cardiol     Publication Date:  1994 Jun 
Date Detail:
Created Date:  1994-09-23     Completed Date:  1994-09-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7903272     Medline TA:  Clin Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  345-7     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Geisinger Medical Center, Danville, Pennsylvania 17822.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Compartment Syndromes / etiology*
Forearm
Humans
Male
Middle Aged
Myocardial Infarction / drug therapy
Thrombolytic Therapy / adverse effects*
Tissue Plasminogen Activator / adverse effects
Chemical
Reg. No./Substance:
EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Radiofrequency catheter ablation of both atrial ventricular nodal reentrant and atrial ventricular r...
Next Document:  The Chronic Arthritis Systemic Index (CASI).